Paul Bisaro

Paul Bisaro, listed as senior executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Mallinckrodt plc, Zoetis Inc. and Myriad Genetics Inc. In total, 25 filings cover trades dated from 10 August 2021 to 4 June 2026.

Every open-market trade on record is a purchase: 4 purchases worth €226k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 8 share grants and 12 option exercises. 2026 to date brings 2 purchases and no sales.

Half of the purchases are above €37k and half below. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 5 June 2026: a share grant, in Myriad Genetics Inc. The clock since the last published purchase (14 May 2026) now reads 157 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.